Novartis AG (Novartis AG) Investments And Advances : $2,582 Mil (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Novartis AG Investments And Advances?

Novartis AG's Investments And Advances for the quarter that ended in Mar. 2024 was $2,582 Mil.

Novartis AG's quarterly Investments And Advances declined from Sep. 2023 ($2,122 Mil) to Dec. 2023 ($1,827 Mil) but then increased from Dec. 2023 ($1,827 Mil) to Mar. 2024 ($2,582 Mil).

Novartis AG's annual Investments And Advances declined from Dec. 2021 ($2,268 Mil) to Dec. 2022 ($1,606 Mil) but then increased from Dec. 2022 ($1,606 Mil) to Dec. 2023 ($1,827 Mil).

Novartis AG Investments And Advances Historical Data

The historical data trend for Novartis AG's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Investments And Advances Chart

Novartis AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Investments And Advances

Get a 7-Day Free Trial

10,434.00

11,611.00

2,268.00

1,606.00

1,827.00

Novartis AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Investments And Advances	Get a 7-Day Free Trial															2,555.00	2,433.00	2,122.00	1,827.00	2,582.00

Novartis AG Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.

Novartis AG (Novartis AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (OTCPK:NVSEF) » Definitions » Investments And Advances

Comparable Companies

Traded in Other Exchanges

NVS:USA NVS N:Mexico NOVNz:UK 0QLR:UK NOTA:Germany NOTA:Germany NOVNEE:Switzerland NOVN:Switzerland N1VS34:Brazil NVS:Argentina

Address

Lichtstrasse 35, Basel, CHE, 4056

Website

https://www.novartis.com

Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.